Market Tracker

12/19 11:01pm ET

Alexion Pharmaceuticals Inc (NASDAQ:ALXN)

189.53
Data as of Dec 19
 +0.57 / +0.30%
Today’s Change
126.08
Today|||52-Week Range
203.30
+42.63%
Year-to-Date

Today’s Trading

Previous close188.96
Today’s open189.04
Day’s range187.68 - 191.56
Volume2,088,291
Average volume (3 months)1,174,494
Market cap$37.6B
Dividend yield--
Data as of 3:59pm ET, 12/19/2014

Growth & Valuation

Earnings growth (last year)-0.78%
Earnings growth (this year)+68.86%
Earnings growth (next 5 years)+25.35%
Revenue growth (last year)+34.85%
P/E ratio79.0
Price/Sales17.19
Price/Book15.67

Competitors

 Today’s
change
Today’s
% change
SHPGShire-4.15-1.88%
VRTXVertex Pharmaceutica...+1.16+0.99%
VRXValeant Pharmaceutic...+3.06+2.14%
PRGOPerrigo Company PLC+3.29+2.00%
Data as of 4:14pm ET, 12/19/2014

Financials

Next reporting dateFebruary 12, 2015
EPS forecast (this quarter)$1.29
Annual revenue (last year)$1.5B
Annual profit (last year)$252.9M
Net profit margin16.73%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, CEO, Treasurer &
Director
Leonard Bell
Chief Operating Officer &
Director
David L. Hallal
Corporate headquarters
Cheshire, Connecticut

Forecasts